What is Oric Pharmaceuticals, Inc.'s preferred stock?

Oric Pharmaceuticals, Inc. (ORIC) reported preferred stock of $0 in Q1 2026.

What does preferred stock mean?

Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.

Oric Pharmaceuticals, Inc. ORIC Preferred Stock

Preferred Stock at other companies

Inhibrx Biosciences, Inc.INBX

$0—

Erasca, Inc.ERAS

$0—

Medpace Holdings, Inc.MEDP

$0—

Ethos Technologies, Inc. LIFE

$2K0.0%

GRAIL, Inc.GRAL

$0—

Other financials

Income statement

See full

Operating income-$39.6M-21.1%

Net income-$35.8M-19.1%

EPS (diluted)-$0.34+19.0%

Balance sheet

See full

Cash & equivalents$56.4M+14.3%

Total debt$3.3M+2.6%

Total equity$415.6M+89.1%

Total assets$436.8M+79.8%

Cash flow

See full

Operating cash flow-$32.4M+0.3%

CapEx$2.0K-99.5%

Free cash flow-$32.4M+1.5%

Valuation

See full

Market cap$976.17M+23.0%

Enterprise value$923.07M+23.5%

Returns & leverage

See full

Return on equity-42.6%-4.6pp

Debt / equity0×0.0×

Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s preferred stock?: Oric Pharmaceuticals, Inc. (ORIC) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?: Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.